AgriBusiness Global Podcasts

Verdesian Life Sciences’ Clare Doyle on Bio-Tech Solutions in 2026

Clare Doyle, chief scientist at Verdesian Life Sciences, outlined the company’s 2026 bio‑tech roadmap, emphasizing engineered nutrient‑delivery platforms and AI‑driven field management. She highlighted partnerships with agri‑tech startups to accelerate gene‑edited microbial solutions and noted upcoming regulatory filings for next‑generation bio‑formulations. Doyle projected that these innovations will cut input costs, reduce environmental impact, and position Verdesian ahead of competitors still using legacy chemicals. The outlook reflects a broader industry shift toward sustainable, data‑integrated agriculture solutions.